{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:47:28Z","timestamp":1788299248326,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K09119"],"award-info":[{"award-number":["23K09119"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08655"],"award-info":[{"award-number":["22K08655"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H02959"],"award-info":[{"award-number":["23H02959"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012029","name":"Tsuchiya Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008672","name":"Yamaguchi Endocrine Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbadis.2025.168087","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:43:50Z","timestamp":1761183830000},"page":"168087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pin1 mediates metabolic dysfunction-associated steatohepatitis in mice fed high-fat, high-cholesterol diet by regulating both PPAR\u03b1 and acetyl CoA carboxylase"],"prefix":"10.1016","volume":"1872","author":[{"given":"Yusuke","family":"Nakatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuka","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machi","family":"Kanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoichiro","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.168087_bb0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2025.168087_bb0010","article-title":"NAFLD Nomenclature consensus group. NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2023","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbadis.2025.168087_bb0015","article-title":"Insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD): pathways of action of hypoglycemic agents","volume":"29","author":"Maldonado-Rojas","year":"2023","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbadis.2025.168087_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.bbadis.2025.168087_bb0025","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.168087_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2006.02.028","article-title":"Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet","volume":"536","author":"Nagasawa","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168087_bb0035","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting","volume":"103","author":"Kersten","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.168087_bb0040","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","article-title":"The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes","volume":"20","author":"Vega","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2025.168087_bb0045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2025.168087_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1096\/fasebj.8.1.7905448","article-title":"Regulation of lipogenic enzyme gene expression by nutrients and hormones","volume":"8","author":"Girard","year":"1994","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2025.168087_bb0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.168087_bb0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14656566.2014.876992","article-title":"New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease","volume":"15","author":"Sahebkar","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.bbadis.2025.168087_bb0065","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3390\/ijms17091495","article-title":"Physiological and pathogenic roles of prolyl isomerase Pin1 in metabolic regulations via multiple signal transduction pathway modulations","volume":"17","author":"Nakatsu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168087_bb0070","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrm2261","article-title":"The prolyl isomerase PIN 1: a pivotal new twist in phosphorylation signalling and disease","volume":"8","author":"Lu","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.168087_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2019.10.043","article-title":"Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells","volume":"470","author":"Nakatsu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2025.168087_bb0080","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s000180050026","article-title":"Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism","volume":"56","author":"Zhou","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2025.168087_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154459","article-title":"Prolyl isomerase Pin1 interacts with adipose triglyceride lipase and negatively controls both its expression and lipolysis","volume":"115","author":"Nakatsu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2025.168087_bb0090","doi-asserted-by":"crossref","first-page":"23294","DOI":"10.1074\/jbc.M111.313684","article-title":"Pin1 protein regulates Smad protein signaling and pulmonary fibrosis","volume":"287","author":"Shen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.168087_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.620238","article-title":"Pin1 promotes NLRP3 inflammasome activation by phosphorylation of p38 MAPK pathway in septic shock","volume":"12","author":"Dong","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.168087_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108847","article-title":"Hepatic Pin1 expression, particularly in nuclei, is increased in NASH patients in accordance with evidence of the role of Pin1 in lipid accumulation shown in hepatoma cell lines","volume":"24","author":"Kanna","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168087_bb0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000365415","article-title":"Can serum pin1 level be regarded as an indicative marker of nonalcoholic steatohepatitis and fibrotic stages?","volume":"90","author":"Cengiz","year":"2014","journal-title":"Digestion"},{"key":"10.1016\/j.bbadis.2025.168087_bb0110","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.celrep.2019.02.066","article-title":"Prolyl isomerase Pin1 suppresses thermogenic programs in adipocytes by promoting degradation of transcriptional co-activator PRDM16","volume":"26","author":"Nakatsu","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2025.168087_bb0115","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.18632\/oncotarget.26691","article-title":"Prolyl isomerase Pin1 binds to and stabilizes acetyl CoA carboxylase 1 protein, thereby supporting cancer cell proliferation","volume":"10","author":"Ueda","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2025.168087_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/jpet.121.000786","article-title":"Selective acetyl-CoA carboxylase 1 inhibitor improves hepatic steatosis and hepatic fibrosis in a preclinical nonalcoholic steatohepatitis model","volume":"379","author":"Tamura","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2025.168087_bb0125","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.168087_bb0130","article-title":"Circulating Indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH","volume":"5","author":"Moore","year":"2023","journal-title":"JHEP Rep."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168087_bb0135","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.168087_bb0140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cmet.2013.12.017","article-title":"Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans","volume":"19","author":"Lee","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.168087_bb0145","doi-asserted-by":"crossref","first-page":"44526","DOI":"10.1074\/jbc.M112.397133","article-title":"Role of Pin1 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent model","volume":"287","author":"Nakatsu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.168087_bb0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1101\/gad.177857.111","article-title":"FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis","volume":"26","author":"Fisher","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2025.168087_bb0155","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2025.168087_bb0160","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1038\/s41598-020-64902-8","article-title":"Pemafibrate, a selective PPARalpha modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content","volume":"10","author":"Sasaki","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.168087_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/srep42477","article-title":"Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis","volume":"7","author":"Honda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.168087_bb0170","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2337\/db15-1637","article-title":"Hepatic ATF6 increases fatty acid oxidation to attenuate hepatic steatosis in mice through peroxisome proliferator-activated receptor alpha","volume":"65","author":"Chen","year":"2016","journal-title":"Diabetes"},{"issue":"2023","key":"10.1016\/j.bbadis.2025.168087_bb0175","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/biom13081264","article-title":"Current clinical trial status and future prospects of PPAR-targeted drugs for treating nonalcoholic fatty liver disease","volume":"13","author":"Kamata","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbadis.2025.168087_bb0180","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/hep.30097","article-title":"Acetyl-CoA carboxylase inhibition reverses NAFLD and hepatic insulin resistance but promotes hypertriglyceridemia in rodents","volume":"68","author":"Goedeke","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2025.168087_bb0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2018.08.020","article-title":"Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma","volume":"29","author":"Lally","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.168087_bb0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12072-017-9841-y","article-title":"Pathogenesis of non-alcoholic fatty liver disease mediated by YAP","volume":"12","author":"Chen","year":"2018","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbadis.2025.168087_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113544","article-title":"Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complex","volume":"425","author":"Aoyama","year":"2023","journal-title":"Exp. Cell Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925004375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925004375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:24:19Z","timestamp":1779524659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925004375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0925443925004375"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168087","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pin1 mediates metabolic dysfunction-associated steatohepatitis in mice fed high-fat, high-cholesterol diet by regulating both PPAR\u03b1 and acetyl CoA carboxylase","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"168087"}}